Lee Ainslie’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.15M Buy
+13,323
New +$1.17M 0.01% 171
2021
Q4
– Sell
-13,528
Closed -$1.7M – 512
2021
Q3
$1.7M Sell
13,528
-7,787
-37% -$1.01M 0.02% 200
2021
Q2
$2.65M Buy
21,315
+6,067
+40% +$762K 0.02% 140
2021
Q1
$1.8M Sell
15,248
-568
-4% -$66.6K 0.02% 161
2020
Q4
$1.85M Buy
+15,816
New +$1.74M 0.03% 141
2019
Q1
– Sell
-44,470
Closed -$4.04M – 308
2018
Q4
$4.04M Buy
+44,470
New +$4.16M 0.06% 205

Other funds holding MDT

Lee Ainslie's MDT Position: Q3 2026 in Review

Lee Ainslie opened a new position in Medtronic (MDT) in Q3 2026: 13,323 shares worth $1.15M. The stake represents 0.01% of the portfolio and ranks #171 among its holdings. This is a return to the name: Lee Ainslie previously reported a position in MDT as recently as Q3 2021.

Lee Ainslie first reported a position in MDT in Q4 2018 and has held it in 6 quarters since. The position peaked at $4.04M in Q4 2018. 2,197 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Lee Ainslie held 13,323 shares of Medtronic worth $1.15M as of Q3 2026.
  • Medtronic was a new Lee Ainslie position in Q3 2026.
  • Medtronic made up 0.01% of Lee Ainslie's portfolio in Q3 2026, its #171 holding.
  • Lee Ainslie first reported a position in Medtronic in Q4 2018 and has held it in 6 quarters since.
  • Lee Ainslie's Medtronic position peaked at $4.04M in Q4 2018.
  • 2,197 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Maverick Capital's 13F filing for Q3 2026, filed 16 Nov 2026.